Lithium intoxication-induced acute Parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: Report of a case

Acta Neurologica Taiwanica

Volumn 16, Issue 4, 2007, Pages 231-233

  Shen, Hsiu Chu ^a   Li, Jie Yuan ^a   Lo, Yuk Keung ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Lithium; Nephrogenic DI; Parkinsonism

Indexed keywords

AMILORIDE; CLONAZEPAM; HYDROCHLOROTHIAZIDE; LEVODOPA; LITHIUM CARBONATE; NAPROXEN; VALPROIC ACID;

AGED; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERPARATHYROIDISM; LABORATORY TEST; NEPHROGENIC DIABETES INSIPIDUS; PARKINSONISM; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; HUMANS; HYPERPARATHYROIDISM; LITHIUM CARBONATE; PARKINSONIAN DISORDERS;

EID: 37549039020     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol 2006;20:347-55.
2. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 1999;10:666-74.
3. Meinardi JR, Donders SH. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient. Neth J Med 1997;50: 105-9.
4. Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol 1997;20:283-99.
5. Dallocchio C, Mazzarello P. A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole. J Clin Neurosci 2002;9:310-1.
6. Bell AJ, Cole A, Eccleston D, et al. Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993;162:689-92.
7. Gadallah MF, Feinstein EI, Massry SG. Lithium intoxication: clinical course and therapeutic considerations. Miner Electrolyte Metab 1988;14:146-9.
8. Muthane UB, Prasad BN, Vasanth A, et al. Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate. J Neurol Sci 2000;176: 78-9.
9. Li Y, Shaw S, Kamsteeg EJ, et al. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenyl cyclase activity. J Am Soc Nephrol 2006;17:1063-72.
10. Khandwala HM, Van Uum S. Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract 2006;12: 54-8.
11. Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 2003;27:486-8.